| abstract |
[Problem] To provide a vaccine preparation and an adjuvant that avoids the phenomenon of bel paralysis more frequently than naturally occurring. One or more carboxylic acids such as lauric acid, myristic acid, erucic acid, and nervonic acid, or laurylamine (C12), myristylamine (C14), palmitolylamine (C16: 1) and oleylamine Use in adjuvants and vaccines comprising one or more amines such as (C18: 1) and optionally one or more monoglycerides. [Selection figure] None |